George Elston insider trades

Open-market stock purchases and sales by George Elston, Chief Financial Officer at EyePoint, Inc, from SEC Form 4 filings since Sep 22, 2010.

Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +249%.

Recent trades

DateStockTradeValue
Aug 20, 2026EYPT EyePoint, IncBought (not open market)—
Aug 20, 2026EYPT EyePoint, IncBought (not open market)—
May 25, 2026EYPT EyePoint, IncSold (not open market)$46.9K
May 25, 2026EYPT EyePoint, IncBought (not open market)—
Mar 2, 2026EYPT EyePoint, IncBought (not open market)—
Jan 6, 2026EYPT EyePoint, IncSold (not open market)$75.7K
Jan 6, 2026EYPT EyePoint, IncBought (not open market)—
Jan 5, 2026EYPT EyePoint, IncSold (not open market)$76.7K
Jan 5, 2026EYPT EyePoint, IncBought (not open market)—
Jan 3, 2026EYPT EyePoint, IncSold (not open market)$111K
Jan 3, 2026EYPT EyePoint, IncBought (not open market)—
Jan 2, 2026EYPT EyePoint, IncBought (not open market)—
Jan 2, 2026EYPT EyePoint, IncBought (not open market)—
Dec 19, 2025EYPT EyePoint, IncBought (not open market)—

Companies traded

  • EYPT EyePoint, Inc: 4 buys, last Aug 20, 2026
  • JNP Juniper Pharmaceuticals Inc: 1 buy, last Aug 31, 2016
  • CLDX Celldex Therapeutics, Inc: other filings, last Jun 8, 2016
  • CBRX Columbia Laboratories Inc: other filings, last Oct 1, 2014

Get free alerts when George Elston files a new trade →